Bulbocapnine

From WikiMD's WELLNESSPEDIA

Bulbocapnine is an alkaloid found in several varieties of plants, including Corydalis and Dicentra, plants that belong to the family Papaveraceae. It is known to cause a temporary paralysis of motor function and has been used in the past as a muscle relaxant. However, its use has been largely discontinued due to the availability of safer alternatives.

Chemistry[edit]

Bulbocapnine is a member of the benzylisoquinoline class of alkaloids. It is structurally similar to other alkaloids in this class, such as papaverine and morphine. The compound is composed of a benzylisoquinoline backbone with a methylenedioxy group and a dimethoxy group attached.

Pharmacology[edit]

The exact mechanism of action of bulbocapnine is not well understood. It is known to act as a dopamine antagonist, blocking the action of dopamine in the brain. This can lead to a variety of effects, including motor paralysis, sedation, and hypotension. However, the compound is also known to have a high toxicity, which has limited its use in medicine.

Medical Use[edit]

Historically, bulbocapnine was used as a muscle relaxant and as a treatment for Parkinson's disease. However, due to its high toxicity and the availability of safer alternatives, it is no longer used for these purposes.

Toxicity[edit]

Bulbocapnine is known to be highly toxic. Symptoms of bulbocapnine poisoning can include motor paralysis, sedation, and hypotension. In severe cases, it can lead to respiratory failure and death.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.